Marco Moretti
Impact in
- Urology top 5%
- Urinary Bladder and Prostate Research
Papers in
-
- COVID-19 Clinical Research Studies 3
-
- Inflammasome and immune disorders 3
- Co-authors
- F. Mantovani (1 shared paper)Johan Van Laethem (4 shared papers)Denis Piérard (4 shared papers)Alessandro Agostini (2 shared papers)Mauro Ercolani (2 shared papers)Massimo Campieri (2 shared papers)Manu L. N. G. Malbrain (1 shared paper)Jacopo Sabbatinelli (3 shared papers)
- Journals
- Mechanisms of Ageing and Development (2 papers)Infectious Diseases (2 papers)American Journal of Infection Control (2 papers)International Journal of STD & AIDS (2 papers)Sexually Transmitted Diseases (1 paper)
- Partner nations
- ItalyBelgiumSwitzerland
In The Last Decade
Marco Moretti
30 papers receiving 457 citations
Peers
Comparison fields: 5 of 86
- Applied Microbiology and Biotechnology 19
- Urology 56
- Rheumatology 86
- Critical Care and Intensive Care Medicine 26
- Drug Discovery 1
Countries citing papers authored by Marco Moretti
This map shows the geographic impact of Marco Moretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Moretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Moretti more than expected).
Fields of papers citing papers by Marco Moretti
This network shows the impact of papers produced by Marco Moretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Moretti. The network helps show where Marco Moretti may publish in the future.
Co-authors
The 25 scholars most cited alongside Marco Moretti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 121 | |
| 2 | 2020 | 91 | |
| 3 | 2017 | 58 | |
| 4 | 2021 | 38 | |
| 5 | 2014 | 36 | |
| 6 | 2022 | 23 | |
| 7 | 2021 | 14 | |
| 8 | 2021 | 9 | |
| 9 | 2013 | 9 | |
| 10 | 2020 | 8 | |
| 11 | 2023 | 6 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 5 | |
| 14 | 2024 | 4 | |
| 15 | 2024 | 4 | |
| 16 | 2024 | 4 | |
| 17 | 2000 | 4 | |
| 18 | 2022 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2021 | 3 |
About Marco Moretti
Marco Moretti is a scholar working on Infectious Diseases, Molecular Biology, Physiology, Surgery and Endocrinology, having authored 34 papers that have together received 464 indexed citations. Recurring topics across this work include Legionella and Acanthamoeba research (3 papers), Inflammasome and immune disorders (3 papers), COVID-19 Clinical Research Studies (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Streptococcal Infections and Treatments (2 papers), Pneumonia and Respiratory Infections (2 papers), Nosocomial Infections in ICU (2 papers) and Poxvirus research and outbreaks (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (19 citations), Urology (56 citations), Rheumatology (86 citations), Critical Care and Intensive Care Medicine (26 citations) and Drug Discovery (1 citation). Marco Moretti has collaborated with scholars based in Italy, Belgium and Switzerland. Frequent co-authors include F. Mantovani, Johan Van Laethem, Denis Piérard, Alessandro Agostini, Mauro Ercolani, Massimo Campieri, Manu L. N. G. Malbrain, Jacopo Sabbatinelli, Antonio Domenico Procopio and Angelica Giuliani. Their work appears in journals such as Mechanisms of Ageing and Development, Infectious Diseases, American Journal of Infection Control, International Journal of STD & AIDS and Sexually Transmitted Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.